Phentermine vs. Reductil (Sibutramine): Differences, Safety and Withdrawal Explained

Phentermine is a short-term appetite suppressant that stimulates the release of norepinephrine in the brain. Reductil, whose active ingredient is sibutramine, blocked the reuptake of serotonin and norepinephrine and was approved for longer-term use. Reductil was withdrawn in the US, EU, Canada, Australia, India, China and many other countries after a large trial found a higher risk of heart attack and stroke in people with existing heart disease. Phentermine remains available in some countries, including the US, as a short-term option for eligible adults. Its use needs medical screening because it also affects the heart and blood pressure. This guide explains how each medicine works, how effective they were, how their side effects and heart risks compare, why Reductil was withdrawn, and where phentermine fits today.

Feature	Phentermine	Reductil (sibutramine)
Drug type	Sympathomimetic amine (stimulant-like appetite suppressant)	Serotonin-norepinephrine reuptake inhibitor (SNRI)
Main brand names	Adipex-P, Lomaira (US)	Reductil (many countries), Meridia (US)
Intended use	Short-term weight management	Longer-term weight management (up to about 1 year in trials)
Current status	Prescribed in some countries (US: Schedule IV)	Withdrawn in most countries since 2010
Main safety concern	Raised heart rate and blood pressure, dependence potential	Increased risk of heart attack and stroke in high-risk patients
Typical half-life	About 20 hours	Active metabolites about 14 to 16 hours

What Is Phentermine and How Does It Work?

Phentermine is a prescription appetite suppressant that has been used since the late 1950s. In the US it is sold as Adipex-P (tablets and capsules) and Lomaira (8 mg tablets). It is also a component of the combination product Qsymia (phentermine and topiramate extended-release). In the US, phentermine is a Schedule IV controlled substance, which reflects a lower but real potential for misuse.

How Phentermine Works

Norepinephrine release: Phentermine mainly increases the release of norepinephrine, a brain chemical involved in alertness and the “fight or flight” response, in the hypothalamus, the brain region that helps regulate hunger.
Reduced appetite: This leads to a lower sense of hunger and an earlier feeling of fullness for many people.
Mild effects on other chemicals: It may have smaller effects on dopamine and serotonin, but these are less central to how it works.
Stimulant-like body effects: Because norepinephrine also acts on the heart and blood vessels, phentermine can raise heart rate and blood pressure.

Who It Is Meant For

In the US, phentermine is approved as a short-term addition to a reduced-calorie diet and exercise for adults with obesity (generally a BMI of 30 or higher) or, in some cases, a BMI of 27 or higher with weight-related conditions such as high blood pressure or type 2 diabetes. It is not a standalone solution, and it is not a cosmetic weight loss drug for people at a healthy weight.

What Was Reductil (Sibutramine) Used For?

Reductil is the brand name used in Europe, Australia, India and many other markets for sibutramine. In the US the same drug was sold as Meridia. It was approved in the late 1990s and early 2000s as a treatment for obesity, alongside diet and exercise.

Original Approved Uses

Obesity management: Typically for adults with a BMI of 30 or higher, or 27 or higher with other risk factors.
Longer-term treatment: Unlike phentermine, sibutramine was studied and used for periods of up to a year or more, which was part of its appeal.
Weight maintenance: Trials also looked at whether it helped people keep weight off after initial loss.

Sibutramine was also a Schedule IV controlled substance in the US. Today it is not an approved treatment in most countries, and the sections below explain why.

How Phentermine and Reductil Affect Appetite

Both medicines were designed to reduce hunger, but they act on the brain’s appetite signals in different ways.

Phentermine and Appetite

Phentermine lowers hunger by increasing norepinephrine activity.
Many users notice reduced appetite within days of starting.
The appetite effect can fade over weeks as the body adjusts (tolerance), which is one reason it is approved for short courses.

Reductil and Appetite

Sibutramine blocked the reuptake of serotonin and norepinephrine, so these chemicals stayed active in the brain for longer.
The result was an earlier feeling of fullness (satiety) during meals, and in some studies, less urge to eat between meals.
It also appeared to increase energy expenditure slightly, though this effect was modest.

In plain terms: Phentermine mainly turned down hunger. Sibutramine mainly turned up fullness. Neither replaces the need for lasting changes to eating, activity, sleep and stress management.

Phentermine vs. Reductil: How Do They Work Differently?

Although both change brain chemistry to reduce appetite, their mechanisms are not the same.

Key Mechanism Differences

Release vs. reuptake: Phentermine triggers the release of norepinephrine. Sibutramine blocks reuptake of serotonin and norepinephrine, so those chemicals linger.
Serotonin involvement: Sibutramine had a direct, significant serotonin effect. Phentermine’s serotonin effect is minor. This is why sibutramine carried a clear risk of serotonin syndrome when combined with other serotonergic drugs.
Active metabolites: Sibutramine is a prodrug. Its active metabolites (called M1 and M2) do most of the work and last longer in the body.
Drug class relatives: Sibutramine is related to SNRI antidepressants, though it was developed for weight management. Phentermine is related to amphetamines, though it is considerably milder.

Why This Matters for Safety

Both drugs raised heart rate and blood pressure in many users. The key difference is that sibutramine’s use over longer periods in people with existing cardiovascular disease produced a measurable rise in serious heart and stroke events in a large outcomes trial. This has never been studied in a trial of that kind, which is a limit on what can be said about its long-term heart safety.

Phentermine vs. Reductil for Weight Loss

Phentermine for Weight Loss

This is typically prescribed at a daily dose in the range of 8 mg up to 37.5 mg, depending on the product and the clinician’s plan. Most people take it in the morning, because later doses can cause insomnia. It is meant to be paired with calorie reduction, physical activity and behavioral support.

Reductil for Weight Loss

Reductil was typically started at a low daily dose and increased if needed, with blood pressure and pulse checks during treatment. Because it was approved for longer use, patients often stayed on it for six months to a year, with guidance to stop if weight loss was insufficient.

Practical Differences

Treatment length: Phentermine is short-term by label. Reductil was approved for longer therapy.
Monitoring: Both required blood pressure and heart rate checks. Reductil’s labeling was especially strict about stopping if blood pressure rose.
Lifestyle support: Clinical guidance for both stressed diet, activity and behavior change, since weight is often regained after stopping any medicine without those habits in place.

Note: Reductil is not an option to seek out today. Its role in this article is historical and for comparison.

How Effective Are Phentermine and Reductil for Weight Management?

Results vary widely from person to person, and drug trials usually report placebo-subtracted weight loss, meaning the extra weight lost beyond what the placebo group achieved.

Phentermine Results

Trials were mostly short, often 12 to 28 weeks, and many were older or small by modern standards.
Reviews generally find that phentermine produces more weight loss than placebo over a few months, with average extra loss in the range of roughly 3 to 4 kg (about 6 to 9 lb) in short trials, though individual results differ a lot.
Long-term data are limited, so what happens after months or years of use is less certain.

Reductil Results

Sibutramine had stronger long-term evidence than phentermine, including trials lasting a year or more.
Average extra weight loss compared with placebo was about 4 to 5 kg (roughly 9 to 11 lb) at one year in many trials.
Some people also showed improvements in waist size, triglycerides and blood sugar. These benefits had to be weighed against its blood pressure and heart effects.

What the Numbers Do Not Show

Weight loss was often regained after stopping either drug, particularly without lasting lifestyle change.
Average results hide big differences. Some people lose little, while others lose much more.
Newer prescription options, including GLP-1 based medicines, have produced larger average weight loss in trials than either phentermine or sibutramine did. Which option is suitable depends on health history, cost and access.

Phentermine vs. Reductil: Differences in Side Effects

Both drugs shared many side effects, since both act on norepinephrine, but each had distinct patterns.

Shared Side Effects

Dry mouth
Constipation
Insomnia and restlessness
Headache and dizziness
Increased heart rate and palpitations
Raised blood pressure
Anxiety or irritability

More Associated with Phentermine

Jitteriness and nervousness, similar to caffeine but stronger
Euphoria or mood elevation in some users, which contributes to misuse risk
Diarrhea or stomach upset
Changes in sex drive
Rarely, pulmonary hypertension (high pressure in the lung arteries), a serious condition reported with older appetite suppressants, so unexplained shortness of breath or swelling needs prompt evaluation

More Associated with Reductil

Sweating and flushing
Nausea and taste changes
Serotonin-related effects such as agitation, tremor or, in rare cases, serotonin syndrome when combined with other serotonergic drugs
Persistent blood pressure and pulse increases, which sometimes meant stopping treatment

When to Seek Medical Attention

Contact a clinician urgently for chest pain, fainting, severe headache, shortness of breath, swelling of the legs, an irregular or very fast heartbeat, or mood changes such as severe agitation or hallucinations. Call emergency services for chest pain, signs of stroke or severe breathing difficulty.

Cardiovascular Risks of Phentermine and Reductil

Heart and blood vessel safety is the central issue in this comparison.

Why These Drugs Affect the Heart

Both drugs increase norepinephrine activity. In the cardiovascular system, that tends to:

Raise heart rate
Raise blood pressure
Increase the workload of the heart

For a healthy person, these changes are often small. For someone with existing heart disease, high blood pressure or stroke history, they can matter a great deal.

Reductil and the SCOUT Trial

The Sibutramine Cardiovascular Outcomes (SCOUT) trial enrolled more than 10,000 people aged 55 and older who were overweight or obese and had existing cardiovascular disease, type 2 diabetes or both. After the results, regulators concluded that:

Participants taking sibutramine had a higher rate of non-fatal heart attack and non-fatal stroke than those on placebo, roughly a 16% relative increase.
The weight loss achieved was modest, so the benefit did not outweigh the added cardiovascular risk for that population.

Phentermine and the Heart

Phentermine’s label warns against use in people with symptomatic cardiovascular disease, uncontrolled hypertension, arrhythmias, or hyperthyroidism.
Large cardiovascular outcomes trials of phentermine alone have not been completed. This is a real evidence gap and a reason clinicians screen carefully, check blood pressure and pulse, and prefer short courses.
Some observational studies have not shown clear excess heart events in carefully selected patients, but they cannot replace a dedicated trial.

Bottom line: Neither medicine is suitable for people with significant heart disease. Phentermine is used in selected lower-risk patients under supervision. Reductil is no longer available through legitimate channels.

How Long Are Phentermine and Reductil Used for Weight Loss?

Phentermine Duration

The US label approves phentermine for short-term use, typically a few weeks, because the original trials were short and appetite effects fade.
Some clinicians prescribe it for longer periods in selected patients, sometimes in intermittent courses, with ongoing monitoring. That practice goes beyond the formal label and should only happen under close medical supervision.
Treatment should be reassessed if weight loss stalls, side effects appear, or blood pressure rises.

Reductil Duration

Sibutramine was approved for longer-term therapy, commonly up to one year in many countries.
Prescribers were advised to stop it if weight loss was less than about 5% of body weight after three months, or if the patient regained weight after initial loss.
Regular blood pressure and pulse checks were required.

What Happens After Stopping

Appetite typically returns when either medicine is stopped. Plans should include nutrition support, physical activity and follow-up. Some clinicians combine medication with behavioral therapy to improve long-term results. Never stop a medicine abruptly or extend its use without talking to your prescriber.

Phentermine vs. Reductil: Drug Interactions and Safety Precautions

Interactions are an important safety topic for both medicines. Give your doctor and pharmacist a full list of everything you take, including over-the-counter products and supplements.

Interactions Affecting Phentermine

MAOIs (monoamine oxidase inhibitors): Must not be combined with phentermine, or taken within 14 days of each other, because of the risk of a dangerous blood pressure spike.
Other appetite suppressants and stimulants: Combining stimulants raises the risk of rapid heartbeat, high blood pressure and anxiety.
Decongestants and caffeine: Pseudoephedrine, high-dose caffeine and energy drinks can add to the stimulant effect.
Antidepressants and serotonergic drugs: Caution is needed, and clinicians weigh the risk case by case.
Blood pressure and diabetes medicines: Doses may need adjusting as weight falls or as phentermine changes blood pressure.
Alcohol: Can worsen dizziness and side effects.

Interactions Affecting Reductil (Historical)

MAOIs: Contraindicated.
SSRIs, SNRIs, triptans, St. John’s wort and other serotonergic drugs: Raised the risk of serotonin syndrome.
Medicines that raise blood pressure or heart rate: Compounded cardiovascular effects.
Certain enzyme-inhibiting drugs (such as some antifungals and antibiotics) could raise sibutramine levels.

General Safety Precautions

Do not use phentermine if pregnant, planning pregnancy or breastfeeding, unless a specialist advises otherwise.
Avoid it with a history of drug misuse, glaucoma, or severe anxiety and agitation, unless a clinician has specifically evaluated the risk.
Avoid taking doses late in the day to limit sleep problems.
Do not drive or operate machinery until you know how the medicine affects you.
Store medicines securely and never share your prescription.

Why Was Reductil (Sibutramine) Withdrawn in Many Countries?

Reductil was withdrawn because of a cardiovascular safety signal, not because it was ineffective.

Timeline of Key Events

Late 2000s: The SCOUT trial reported a higher rate of non-fatal heart attacks and strokes among participants taking sibutramine compared with placebo.
January 2010: The European Medicines Agency recommended suspending marketing authorizations because risks outweighed benefits.
2010: Regulators and manufacturers in other regions followed. The US FDA requested withdrawal of Meridia in October 2010, and the manufacturer complied. Canada, Australia, India, China and other countries also withdrew or suspended it around the same time.

Why Regulators Acted

The drug’s weight loss benefit was modest.
Cardiovascular harm was seen in a population that, in real life, often received obesity medicines.
Stricter prescribing limits were considered difficult to enforce in practice.

A Continuing Concern: Hidden Sibutramine in Supplements

Even after withdrawal, regulators including the US FDA have repeatedly found sibutramine secretly added to products marketed as “herbal” or “natural” weight loss supplements. Consumers who take these products may unknowingly be exposed to a withdrawn drug and its heart risks. If a weight loss product promises dramatic results, contains no clear ingredient list, or is sold without a prescription despite strong claims, treat it with caution and ask a pharmacist or doctor first.

Is Phentermine Still Prescribed for Weight Management?

In some countries, yes. In the US, phentermine remains one of the most commonly prescribed weight loss medicines, usually as a short-term option for adults who meet BMI criteria and have no major cardiovascular contraindications.

Where Availability Differs

United States: Available by prescription as a Schedule IV drug.
Other regions: Rules vary widely. In some parts of Europe, phentermine is not authorized for obesity treatment, and in others it is tightly controlled. Always check local regulations and consult a licensed prescriber.

Why It Remains in Use

It is inexpensive compared with newer medicines.
It is taken orally and does not need injections.
It has decades of clinical experience, even if long-term outcome trials are limited.

Modern Alternatives Clinicians May Discuss

GLP-1 receptor agonists and related medicines (such as semaglutide and tirzepatide), which have shown larger average weight loss in trials
Naltrexone-bupropion and phentermine-topiramate
Orlistat, which reduces fat absorption
Bariatric surgery for people with severe obesity
Structured lifestyle and behavioral programs, with or without medication

The best option depends on medical history, goals, cost, access and risk tolerance, which only a qualified clinician can weigh.

Phentermine vs. Reductil: Which Is More Suitable?

Reductil is no longer a suitable or legitimate option. It is not approved in most countries, and products sold under its name or containing sibutramine today may be unregulated or counterfeit. The meaningful question for most people is not “phentermine or Reductil?” but “is phentermine, or another option, appropriate for me?”

When a Clinician May Consider Phentermine

Adults with obesity (or overweight with related conditions) who have not reached goals with lifestyle changes alone
People without significant heart disease, uncontrolled high blood pressure, hyperthyroidism, glaucoma or a history of drug misuse
Patients who can attend follow-up visits for weight, blood pressure and pulse checks

When Phentermine Is Often Avoided

Existing heart disease, stroke, arrhythmia or uncontrolled hypertension
Pregnancy or breastfeeding
Recent use of an MAOI
Significant anxiety, agitation or history of substance misuse

Questions to Ask Your Healthcare Provider

Is a weight loss medicine appropriate for me, and what are non-drug alternatives?
Do my heart health, blood pressure or other conditions make phentermine unsafe?
Do any of my current medicines or supplements interact with it?
How long should I take it, and what is the plan if weight loss stalls?
How will we monitor side effects, and what will happen when I stop?

Consult a licensed doctor, obesity medicine specialist or registered dietitian before making any decision. If you are comparing clinics or telehealth providers, choose accredited, licensed services that require a medical assessment, and be cautious about any seller offering prescription weight loss drugs without a prescription.

Frequently Asked Questions About Phentermine and Reductil

Is phentermine the same as Reductil?

No. Phentermine is a norepinephrine-releasing appetite suppressant. Reductil contains sibutramine, which blocks reuptake of serotonin and norepinephrine. They are different drugs with different mechanisms and safety profiles.

Is Reductil still available?

Reductil was withdrawn or suspended in most countries, including the US, EU, Canada, Australia and India, from about 2010 onward. Any product sold today claiming to contain it is not coming from a legitimate approved supply chain.

Why was sibutramine taken off the market?

A large trial in people with existing cardiovascular disease found more non-fatal heart attacks and strokes with sibutramine than with placebo, and regulators concluded that the risks outweighed the modest weight loss benefit.

Is phentermine safer than Reductil?

Phentermine is still available because it has not been withdrawn, but “still available” does not mean risk-free. It raises heart rate and blood pressure and is unsuitable for people with significant cardiovascular disease. Its long-term cardiovascular safety has not been studied in a large outcomes trial.

Which works better for weight loss?

In trials, sibutramine produced slightly higher average extra weight loss over a year, while phentermine’s data are mostly short-term. Neither is a guarantee, and results vary by person. Newer medicines have shown larger average results than both.

How long can you take phentermine?

The US label approves it for short-term use. Some clinicians prescribe longer or intermittent courses in selected patients, under careful monitoring. Follow your prescriber’s plan.

Can you take phentermine with antidepressants?

It depends on the specific medicine. MAOIs are contraindicated, and other antidepressants require a clinician’s judgment. Never combine them on your own.

Can you drink alcohol or coffee while taking phentermine?

Alcohol can worsen dizziness and side effects, and large amounts of caffeine can add to jitteriness and heart rate. Ask your prescriber about your situation.

Does weight come back after stopping?

Often, yes, particularly if eating and activity habits have not changed. Planning for maintenance should begin before stopping.

Are “herbal Reductil” or “natural sibutramine” supplements safe?

No. Regulators have found withdrawn drugs hidden in some weight loss supplements. Avoid products with unclear ingredients and ask a pharmacist or doctor first.

Conclusion

Phentermine and Reductil were both designed to reduce appetite, but they work differently and have different histories. Phentermine acts mainly by increasing norepinephrine release and remains available in some countries as a short-term, prescription-only option. Reductil (sibutramine) blocked serotonin and norepinephrine reuptake, offered longer-term use, and was withdrawn in most of the world after a trial showed more heart attacks and strokes in high-risk patients.

Medical Disclaimer: This article is for general education only. It is not medical advice, a diagnosis, or a treatment recommendation. Phentermine is a prescription-only controlled medicine in many countries, and Reductil (sibutramine) has been withdrawn from the market in most of the world. Never start, stop, or change any weight loss medicine without a licensed healthcare professional.